The Great Conversation: What Happens When Science Changes Its Mind?
Hello everyone, and welcome to The Great Conversation.
For years, hormone replacement therapy has occupied an uneasy place in discussions about women’s health.
At one point, it was widely prescribed.
Then major studies raised concerns about possible links to dementia, breast cancer, and heart disease, particularly when certain hormone combinations were started later in life.
Use of HRT fell sharply.
Now, new research is complicating that story.
A large UK Biobank study followed more than 183,000 postmenopausal women for an average of 13 years. It found that women who had used HRT for at least one year were less likely to be diagnosed with dementia and Alzheimer’s disease than women who had never used it.
The strongest association appeared in women who had experienced surgical menopause, while women with lower lifetime estrogen exposure also appeared to benefit more. The association was also stronger among women carrying the APOE4 gene variant, which is linked to a higher risk of Alzheimer’s disease.
A separate Stanford study went even further by examining autopsied brains.
Researchers found that women who had used estrogen-only menopausal hormone therapy showed lower levels of the defining biological signs of Alzheimer’s disease, including amyloid plaques and neurofibrillary tangles.
Taken together, these findings are intriguing.
But they are not a final verdict.
The UK study was observational, meaning it can identify an association but cannot prove that HRT itself caused the lower dementia rates.
The Stanford findings were also limited largely to women using estrogen-only therapy, generally after hysterectomy.
And a major 2025 review of the broader scientific literature concluded that the evidence as a whole still did not clearly show that menopausal hormone therapy either increases or decreases dementia risk.
So HRT is not suddenly a dementia prevention drug.
Experts continue to caution against starting or stopping hormone therapy for that purpose based on these studies alone.
Yet this story points toward something larger than HRT.
Science does not move in a straight line.
Evidence accumulates.
Methods improve.
Researchers separate groups that earlier studies treated as identical.
Timing matters.
Dosage matters.
Genetics matter.
Even the form in which a treatment is given can matter.
And sometimes a conclusion that once appeared simple becomes much more complicated when better questions are asked.
That can feel uncomfortable.
We often want science to give us certainty.
A clear yes.
A clear no.
Safe.
Dangerous.
Effective.
Ineffective.
But science is not a collection of permanent answers.
It is a process for improving our answers.
That means changing a conclusion is not necessarily evidence that science failed.
Sometimes it is evidence that the process is working.
The challenge for the rest of us is learning how to live with that uncertainty without falling into either extreme.
We should not treat every new study as a revolution.
But we should not assume yesterday’s conclusion must remain untouched forever either.
Which raises a deeper question...
When new evidence challenges something we once believed was settled, should we see that uncertainty as a weakness in science, or as one of the very mechanisms through which knowledge becomes more reliable?
Take a moment to reflect.
And click the link below to see more on this subject.
